LACEY PRESTON: Open Payments
NPI 1912508532 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,775 in 178 payments from 31 companies in 2025. Trend: 2023 $2,909 · 2024 $3,784 · 2025 $3,775
Food & beverage: $3,703Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $472 |
| PFIZER INC. | 17 | $340 |
| Biogen, Inc. | 13 | $303 |
| Lundbeck LLC | 11 | $287 |
| Alexion Pharmaceuticals, Inc. | 8 | $211 |
| UCB, Inc. | 8 | $203 |
| Teva Pharmaceuticals USA, Inc. | 8 | $190 |
| Neurocrine BioSciences, Inc. | 7 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| EMD Serono, Inc. | 6 | $146 |
Products named: NURTEC ODT, LEQEMBI, VYEPTI, ULTOMIRIS, UBRELVY, REXULTI, INGREZZA, HYQVIA.
Industry payments across GA — which companies pay providers there.
